At 10.6% CAGR, South & Central America Aesthetic Medical Devices Market is Projected to be Worth US$ 2,670.06 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the South & Central America aesthetic medical devices market was valued at US$ 1,195.13 million in 2023 and is expected to reach US$ 2,670.06 million by 2031, registering a CAGR of 10.6% from 2023 to 2031. Rise in medical tourism worldwide and non-invasive aesthetic procedures and technological advancements associated with medical aesthetic devices are among the critical factors attributed to drive the South & Central America aesthetic medical devices market growth.

All medical devices used for various cosmetic procedures, including plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., are categorized as medical aesthetic products. With the establishment of the advanced, high-speed internet infrastructure and the growing social media trend, information is becoming more accessible to everyone; as a result, people are becoming more aware of aesthetic procedures. An increasing number of social media users and the sensitization of the masses to medical aesthetic procedures are correlated with improved sales of aesthetic medical devices.

Several parameters such as clinical improvement, risks, potential complications, and downtime after surgery influenced the required aesthetic outcome associated with cosmetic treatments. These parameters can validate plasma skin regeneration (PSR) technology as a new regenerative modality, as it has great potential in dermatology; it helps treat facial arrhythmias, sun keratosis, seborrheic keratosis, and warts. A few studies have examined the clinical effects of PSR technology on periorbital rejuvenation. With PSR, ~20% and 30% improvement in the tightening of the upper eyelid and the periorbital folds, respectively, were achieved.

After six months, ~40% improvement in acne scars on the face was achieved after the single PSR treatment. PSR has also been explored to rejuvenate the skin of the chest, neck, and back of the hands. In addition, it can be used to treat traumatic scars, benign familial pemphigus, and porokeratosis.

Understanding the impact of PSR technology on aesthetic medicine requires basic knowledge of plasma physics and histopathological aspects. Recent technological advancements will likely bring significant improvements in the aesthetic treatment of the skin. The emergence of laser and light-based technologies is promising among skin rejuvenation therapies. New laser resurfacing techniques for skin rejuvenation offer significant advantages over conventional ablative lasers such as the CO2 and erbium-YAG laser systems. Non-ablative and fractional lasers, although not as effective as ablative therapies, are associated with significantly lower complication rates and shorter recovery periods. Market players are also launching new devices combining ablative and fractional technologies. Thus, technological advancements associated with medical aesthetic devices are anticipated to fuel the aesthetic medical devices market growth in the coming years.

On the contrary, risks and complications associated with procedures and stringent safety regulations hamper the growth of South & Central America aesthetic medical devices market.

Based on technology, the South & Central America aesthetic medical devices market is divided into laser-based, light-based, electromagnetic energy-based, ultrasound-based, cryolipolysis, suction-based, and plasma energy-based. The laser-based segment held 24.9% market share in 2023, amassing US$ 297.62 million. It is projected to garner US$ 678.55 million by 2031 to register 10.9% CAGR during 2023–2031.

In terms of application, the South & Central America aesthetic medical devices market is segmented into facial skin resurfacing, photorejuvenation, hair removal, fat reduction and body contouring, skin tightening, cellulite reduction, feminine rejuvenation, tattoos and pigmentation, acne and acne scars, vascular lesions, and others. The acne and acne scars segment held 19.1% share of South & Central America aesthetic medical devices market in 2023, amassing US$  228.54 million. It is anticipated to garner US$  491.56 million by 2031 to expand at 10.0% CAGR during 2023–2031.

By end user, the South & Central America aesthetic medical devices market is divided dermatology and cosmetic clinics, hospitals and clinics, medical spas, and home use. The dermatology and cosmetic clinics segment held 38.0% share of South & Central America aesthetic medical devices market in 2023, amassing US$ 454.39 million. It is projected to garner US$  1,046.70 million by 2031 to expand at 11.0% CAGR from 2023 to 2031.

Based on country, the South & Central America aesthetic medical devices market is categorized into Brazil, Argentina, Chile,  and the Rest of South & Central America. Our regional analysis states that Brazil captured 58.7% share of South & Central America aesthetic medical devices market in 2023. It was assessed at US$  701.44 million in 2023 and is likely to hit US$  1,613.23 million by 2031, registering a CAGR of 11.0% during 2023–2031.

Key players operating in the South & Central America aesthetic medical devices market are Merz Pharma GmbH & Co KGaA, Bausch Health Companies Inc, Venus Concept Inc,  Fotona, InMode, and Asclepion Laser Technologies GmbH, among others.

• In February 2021, Asclepion Laser Technologies successfully introduced the new nano laser range: The NanoStar Family. The NanoStar family includes three new q-switch laser systems in three separate devices. A ruby laser (694 nm), a Nd:YAG laser (1,064 nm + 532 nm) and a combined device with all of the mentioned wavelengths including the innovative mixed-technology, giving perfect conditions for every need. The family uses the well-known Q-qwitched technology, which allows for treatment of tattoos, pigments and others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com